• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problems Contamination (1120); Improper or Incorrect Procedure or Method (2017)
Patient Problem Peritonitis (2252)
Event Date 11/18/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is for a breach in aseptic technique which resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy.A review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that a patient experienced a breach in aseptic technique which resulted in peritonitis coincident with peritoneal dialysis therapy.The breach in aseptic technique was further described as the patient did not wear a mask.The patient was not hospitalized for the peritonitis event.One day after onset, the patient was treated with vancomycin injection 1 gram intravenously as a stat dose for the peritonitis event and then the vancomycin injection was to be given 1 gram intravenously every fifth day (duration not reported) for the peritonitis event.Beginning one day after onset, the patient was treated with a combination of piperacillin injection plus tazobactam injection 4.5 grams twice a day for fourteen days intravenously for the peritonitis event.It was not reported if dianeal therapy was ongoing.The patient was recovering from the peritonitis event.It was not reported if the patient was retrained on the proper aseptic technique.No additional information is available.
 
Manufacturer Narrative
(b)(4).On an unreported date, the patient was recovered from the previously reported peritonitis event (previously, the outcome was reported as recovering), the antibiotic treatment was completed, and the peritoneal effluent fluid was clear.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
Manufacturer Contact
kinga almasan
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key5293055
MDR Text Key33392977
Report Number1416980-2015-44230
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age42 YR
-
-